BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27907910)

  • 1. A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer.
    Alves IT; Cano D; Böttcher R; van der Korput H; Dinjens W; Jenster G; Trapman J
    Oncotarget; 2017 Jan; 8(4):6043-6056. PubMed ID: 27907910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
    Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
    Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch Repair.
    Walker CJ; Miranda MA; O'Hern MJ; Blachly JS; Moyer CL; Ivanovich J; Kroll KW; Eisfeld AK; Sapp CE; Mutch DG; Cohn DE; Bundschuh R; Goodfellow PJ
    Hum Mutat; 2016 Oct; 37(10):1004-12. PubMed ID: 27346418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers.
    Hienonen T; Sammalkorpi H; Enholm S; Alhopuro P; Barber TD; Lehtonen R; Nupponen NN; Lehtonen H; Salovaara R; Mecklin JP; Järvinen H; Koistinen R; Arango D; Launonen V; Vogelstein B; Karhu A; Aaltonen LA
    Cancer Res; 2005 Jun; 65(11):4607-13. PubMed ID: 15930278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects of DNA mismatch repair in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
    Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
    Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.
    McCoy P; Mangiola S; Macintyre G; Hutchinson R; Tran B; Pope B; Georgeson P; Hong MKH; Kurganovs N; Lunke S; Clarkson MJ; Cmero M; Kerger M; Stuchbery R; Chow K; Haviv I; Ryan A; Costello AJ; Corcoran NM; Hovens CM
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1167-1180. PubMed ID: 34108644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
    Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
    J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancer.
    Sun X; Chen C; Vessella RL; Dong JT
    Prostate; 2006 May; 66(6):660-6. PubMed ID: 16388502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency.
    Yang JL; Qu XJ; Yu Y; Kohn EC; Friedlander ML
    Int J Cancer; 2008 Jul; 123(2):258-263. PubMed ID: 18464258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels.
    Raeker MÖ; Pierre-Charles J; Carethers JM
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):689-704. PubMed ID: 31982570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks.
    Zhao H; Thienpont B; Yesilyurt BT; Moisse M; Reumers J; Coenegrachts L; Sagaert X; Schrauwen S; Smeets D; Matthijs G; Aerts S; Cools J; Metcalf A; Spurdle A; ; Amant F; Lambrechts D
    Elife; 2014 Aug; 3():e02725. PubMed ID: 25085081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes and consequences of microsatellite instability in endometrial carcinoma.
    Gurin CC; Federici MG; Kang L; Boyd J
    Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome.
    Maletzki C; Huehns M; Bauer I; Ripperger T; Mork MM; Vilar E; Klöcking S; Zettl H; Prall F; Linnebacher M
    Mol Carcinog; 2017 Jul; 56(7):1753-1764. PubMed ID: 28218421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability.
    Kuismanen SA; Moisio AL; Schweizer P; Truninger K; Salovaara R; Arola J; Butzow R; Jiricny J; Nyström-Lahti M; Peltomäki P
    Am J Pathol; 2002 Jun; 160(6):1953-8. PubMed ID: 12057899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.
    Haruma T; Nagasaka T; Nakamura K; Haraga J; Nyuya A; Nishida T; Goel A; Masuyama H; Hiramatsu Y
    PLoS One; 2018; 13(4):e0195655. PubMed ID: 29659608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and molecular consequences of microsatellite instability in human cancers].
    Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
    Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.